Seven Biopharma Trends to Watch in 2022
Besides Omicron, the industry will focus on RNA-based drugs, AI programs, gene therapy trials, financing deals, regulatory issues, and synthetic biology challenges.
Source: genengnews.com
Stay updated with breaking news from Davidc Schwartz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Besides Omicron, the industry will focus on RNA-based drugs, AI programs, gene therapy trials, financing deals, regulatory issues, and synthetic biology challenges.